Fundamental Analysis
37 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +4.2% | +52.3% | 3 / 3 | -20.3% | +2.27 pp | +0.42 pp | +5.1% | 1.94 | 29.54 | 765 | −20,3% | 18,9 | −4,1% | 29.54 | 24.56 | +20,3% |
| Pts | 0 | 12 | 12 | 0 | 8 | 8 | 0 | -4 | 4 | |||||||
Valuation annotation:Price: 17.000 (close price on 2026-10-19)EPS (TTM): 575,4
Financial charts
1.Revenue & growth
VND bn765Q2/26
1.Revenue & growth
VND bn765Q2/26
2.Profit & growth
VND bn18,8Q2/26
3.Profit mix (Penman)
VND bn73,9Q2/26
4.Margins & cost structure
%7.3%Q2/26
5.Returns & cash cycle
% · days4.0%Q2/26
6.Earnings quality & cash
VND bn216Q2/26
7.Asset structure
VND bn3.808Q2/26
8.Funding & debt health
VND bn · times3.808Q2/26
9.Revenue backlog
VND bn4,41Q2/26
10.Valuation
times · %31,4×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %217Q2/26
Adjusted EPS growth, latest quarter
4.6%
Average adjusted EPS growth, 3 quarters
52.4%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26